Articles About Epilepsy
Patients are increasingly turning to alternative medicine to treat chronic conditions, but natural remedies can carry a number of risks -- from dangerous side effects to interactions with conventional drugs.
Research advances in the last decade have shown that certain human epilepsy syndromes have a genetic basis. Genetic testing and counseling may help us better understand a patient's prognosis.
There is important information at the extremes of the EEG spectrum, and useful data are discarded when recordings are done at the conventional 1-70 hertz frequency band. Preliminary studies suggest that full band EEG may reduce the need for invasive monitoring and improve surgical outcomes.
Recording from the scalp with a "dense array" of 256 EEG electrodes is a technological advance likely to improve the localization of EEG findings. With reduced interelectrode distances, spatial resolution is markedly improved, and approaches the "spatial Nyquist"- the mininum distance required to maximize spatial information from scalp recordings.
It is important for clinicians working with epilepsy patients to be aware of the increased vulnerability for dementia in older patients. Neuropsychological testing can help differentiate normal age-related changes from more problematic decline.
At the University of Washington Medical Center, we have developed an autonomic nervous system laboratory to perform a series of tests of autonomic function. These tests can determine the presence or absence of ANS disease, quantify the severity and determine the distribution of dysfunction, and improve differential diagnosis and treatment.
Pregabalin, trade name Lyrica, and rufinamide, trade name Banzel are two newer antiepileptic drugs. This article discusses their mechanisms, efficacy, and adverse effects.